ASRS 2023: insights on fluid control with faricimab compared to aflibercept in recent studies with Aleksandra Rachiskaya, MD

News
Video

At the 2023 ASRS annual meeting, Aleksandra Rachiskaya, MD, spoke about time to fluid control with faricimab arms complete compared to aflibercept in recent studies.

Aleksandra Rachiskaya, MD, detailed her 2023 ASRS presentation, focused on time to fluid control with faricimab arms complete compared to aflibercept in recent studies.

Video Transcript

Editor's note - This transcript has been edited for clarity.

Aleksandra Rachiskaya, MD:

So I think when we, when we think about "how does this apply to me? You know, how am I going to take this data, where we see this shorter time to fluid control with faricimab arms complete compared to aflibercept? And how does it apply to my practice?" I think it's quite impactful, bcause we we want to control patients better....We're looking at further analysis to see how this translates to visual acuity outcomes as well. But we want to control the fluid because a lot of our treatment decisions are based on presence or absence of fluid.

So with faricimab drying patients faster, it will impact how we take care of patients in our clinics. So, I think one of the questions that we're looking at as pertaining to this particular topic is, you know, is looking at the visual acuity also. You know, does this faster drying translates into into visual acuity benefits? I'm curious to see how that data comes out and and share it with everybody.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.